Nuclear Complex of EGFR, Src, and Stat3 in Pancreatic Cancer Cells
Author Information
Author(s): Jaganathan Soumya, Yue Peibin, Paladino David C., Bogdanovic Jelena, Huo Qun, Turkson James
Primary Institution: Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, Florida, United States of America
Hypothesis
The study investigates the role of a nuclear heteromeric complex of EGFR, Src, and Stat3 in regulating c-Myc expression in pancreatic cancer cells.
Conclusion
The nuclear EGFR, Src, and Stat3 complex significantly regulates c-Myc expression, contributing to the pancreatic cancer phenotype.
Supporting Evidence
- The nuclear EGFR, Src, and Stat3 complex is associated with the c-Myc promoter.
- Concurrent modulation of Stat3 and EGFR or Src strongly suppressed c-Myc expression.
- EGFR, Src, and Stat3 form a heteromeric complex in the nucleus of pancreatic cancer cells.
Takeaway
This study shows that three proteins, EGFR, Src, and Stat3, work together in the nucleus of pancreatic cancer cells to control a gene called c-Myc, which helps the cancer grow.
Methodology
The study used co-immunoprecipitation, chromatin immunoprecipitation, and dynamic light scattering to analyze the interactions and presence of the EGFR, Src, and Stat3 complex in pancreatic cancer cells.
Limitations
The study does not explore the potential presence of other proteins in the complex or the exact configuration of the heteromeric complex.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website